[1] |
WANG Tiefeng, SU Jie, WANG Weidong, XIA Rongshuang, LI Sifan, ZHU Wenrui, LOU Zhaohuan.
Mechanisms of Radix Tetrastigma on anti rheumatoid arthritis via regulating the balance of Th17/Treg
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 138-146.
|
[2] |
LU Xiaohong, HE Caifeng, Ci Chao, YUAN Tao.
Progress in the treatment of mucosal pemphigoid
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(10): 1197-1200.
|
[3] |
LU Ming, YIN Xiaoyu, ZHANG Zhiqing.
Research progress and mechanism of mesenchymal stem cells in the treatment of autoimmune diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(6): 700-706.
|
[4] |
ZHU Zhengyi, NI Yinghua, GAO Peng, WANG Huijuan, HUANG Lingfei, HU Yan, ZHANG Liwen, YANG Jufei, FANG Luo.
Tocilizumab related adverse events: A cross-section analysis of FDA Adverse Event Reporting System
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(8): 895-902.
|
[5] |
LI Guinv, REN Shaolin, SHEN Ruiming, JI Yongneng, CAI Cairong, SU Ruo.
Metformin combined with glucocorticoid in the treatment of SLE patients with IGT
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(6): 670-676.
|
[6] |
WANG Xiaoxia, WANG Hong, LIU Yan, BAI Jie.
Experience in quality control of clinical trials of DMARDs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(1): 117-120.
|
[7] |
ZOU Lixia,LU Meiping,XU Yiping,ZHENG Qi,ZHENG Rongjun.
Clinical observation of tocilizumab and etanercept for polyarticular course juvenile idiopathic arthritis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(12): 1421-1427.
|
[8] |
CHEN Lanfang, QIANG Fuyong, XU Liang.
Short-term clinical observation of moderate to severe active rheumatoid arthritis treated with tocilizumab combined with disease modifying antirheumatic drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(12): 1386-1391.
|
[9] |
LIU Tingting, YU Wei, YANG Chunlan, SHUAI Zongwen, GAO Beibei, XIA Quan.
Blood concentration monitoring of hydroxychloroquine in patients with autoimmune diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(12): 1359-1363.
|
[10] |
ZHANG Xiaoying, WANG Kang, WU Sha, GUO Peng.
Association analysis of low dose olanzapine in controlling mental symptoms of NMDAR encephalitis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(11): 1292-1296.
|
[11] |
WU Jiaqi, YANG Qiaowen, CHEN Xiumin, HUANG Runyue, HUANG Qingchun, ZHAO Yue, WU Xiaodong.
Efficacy and safety of iguratimod combined with methotrexate in rheumatoid arthritis: A systematic review and Meta-analysis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(10): 1132-1140.
|
[12] |
LU Xiaohong,WANG Peiguang.
Progress in the treatment of dermatomyositis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(7): 836-840.
|
[13] |
CHEN Xinxin, CHEN Chaosheng.
Research progress of long noncoding RNA in systemic lupus erythematosus
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(4): 471-476.
|
[14] |
YU Shuyuan, ZHENG Lin, HAN Fei.
Pathogenesis and treatment progress of antineutrophil cytoplasmic antibody-associated vasculitis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(2): 235-240.
|
[15] |
YANG Hong, LIN Shan, YANG Hong, XIE Xiaowei, WANG Xin.
Effect of Ira Maude on VEGF and PEDF in patients with rheumatoid arthritis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(1): 68-71.
|